Filing Flows › Sanofi (SNY) › Q3 2026 › vs Q2 2026
Sanofi (SNY) Q3 2026 vs Q2 2026 (quarter over quarter)
Sanofi's revenue rose $2.8B (+25%) from $11.6B in Q2 2026 to $14.4B in Q3 2026. Gross margin 80.3% against 80.0% (+0.3 pts).
Sanofi, Q3 2026: revenue $14.4B (+16% year over year), operating margin 30.1%, net earnings $3.0B, operating cash flow $3.9B. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 80.3% | 80.0% | +0.3 pts |
| Operating margin | 30.1% | 9.0% | +21.1 pts |
| Net margin | 20.9% | 3.0% | +18.0 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $14.4B | $11.6B | $2.8B | +25% |
| Gross profit | $11.6B | $9.3B | $2.3B | +25% |
| Cost of revenue | $2.8B | $2.3B | $529M | +23% |
| Operating profit | $4.3B | $1.0B | $3.3B | +315% |
| Operating expenses | $7.3B | $8.2B | −$984M | -12% |
| Pre-tax earnings | $4.2B | $828M | $3.4B | +410% |
| Other expense, net | $125M | $219M | −$94.0M | -43% |
| Research & development | $1.8B | $2.2B | −$384M | -17% |
| Other operating costs | $5.4B | $6.0B | −$600M | -10% |
| Net earnings | $3.0B | $343M | $2.7B | +781% |
| Minority interests | $8.0M | $34.0M | −$26.0M | -76% |
| Income tax | $1.2B | $451M | $744M | +165% |
| Working capital & other | $850M | $2.6B | −$1.8B | -68% |
| Operating cash flow | $3.9B | $3.0B | $911M | +31% |
Questions
How much did Sanofi's revenue grow quarter over quarter in Q3 2026?
Sanofi's revenue rose $2.8B (+25%) from $11.6B in Q2 2026 to $14.4B in Q3 2026. Gross margin 80.3% against 80.0% (+0.3 pts).